Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Rheumatology (Oxford, England)
|
October 26, 2019
Sneddon syndrome associated with two novel ADA2 gene mutations
Thomas J Tull, Blanca Martin, Jo Spencer, et al.
Clinical and Experimental Dermatology
|
May 8, 2026
HLA genotype, clinical and immunofluorescence findings of 30 patients with type VII collagen antibody positive subepidermal bullous disease
Ruman Basra, Rosanna Naderi, Sangeetha Yogarajah, et al.
Frontiers in Immunology
|
March 21, 2019
Reduced CD27<sup>-</sup>IgD<sup>-</sup> B Cells in Blood and Raised CD27<sup>-</sup>IgD<sup>-</sup> B Cells in Gut-Associated Lymphoid Tissue in Inflammatory Bowel Disease
Chathyan Pararasa, Na Zhang, Thomas J Tull, et al.
The British Journal of Dermatology
|
April 2, 2024
Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus
Thomas J Tull, Emma C Benton, Kristina Semkova, et al.
Frontiers in Immunology
|
December 29, 2025
Clinical correlation of anti-desmoglein antibody dynamics in pemphigus treated with rituximab
Vishvan Naidu, Harshita A Jain, Ali Yalcinkaya, et al.
Nature Communications
|
May 14, 2024
Double-negative B cells and DNASE1L3 colocalise with microbiota in gut-associated lymphoid tissue
Lucia Montorsi, Michael J Pitcher, Yuan Zhao, et al.
The British Journal of Dermatology
|
February 26, 2026
Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: A scoping review
Lucy Booth, Xinyi Chen, Katie Stoker, et al.
Science Immunology
|
March 18, 2022
Two subsets of human marginal zone B cells resolved by global analysis of lymphoid tissues and blood
Jacqueline H Y Siu, Michael J Pitcher, Thomas J Tull, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma
Zena N Willsmore, Lucy Booth, Akshay Patel, et al.
Cancers
|
October 16, 2024
Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma
Xinyi Chen, Shabana Habib, Madalina Alexandru, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Rheumatology (Oxford, England)
|
October 26, 2019
Sneddon syndrome associated with two novel ADA2 gene mutations
Thomas J Tull, Blanca Martin, Jo Spencer, et al.
Clinical and Experimental Dermatology
|
May 8, 2026
HLA genotype, clinical and immunofluorescence findings of 30 patients with type VII collagen antibody positive subepidermal bullous disease
Ruman Basra, Rosanna Naderi, Sangeetha Yogarajah, et al.
Frontiers in Immunology
|
March 21, 2019
Reduced CD27<sup>-</sup>IgD<sup>-</sup> B Cells in Blood and Raised CD27<sup>-</sup>IgD<sup>-</sup> B Cells in Gut-Associated Lymphoid Tissue in Inflammatory Bowel Disease
Chathyan Pararasa, Na Zhang, Thomas J Tull, et al.
The British Journal of Dermatology
|
April 2, 2024
Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus
Thomas J Tull, Emma C Benton, Kristina Semkova, et al.
Frontiers in Immunology
|
December 29, 2025
Clinical correlation of anti-desmoglein antibody dynamics in pemphigus treated with rituximab
Vishvan Naidu, Harshita A Jain, Ali Yalcinkaya, et al.
Nature Communications
|
May 14, 2024
Double-negative B cells and DNASE1L3 colocalise with microbiota in gut-associated lymphoid tissue
Lucia Montorsi, Michael J Pitcher, Yuan Zhao, et al.
The British Journal of Dermatology
|
February 26, 2026
Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: A scoping review
Lucy Booth, Xinyi Chen, Katie Stoker, et al.
Science Immunology
|
March 18, 2022
Two subsets of human marginal zone B cells resolved by global analysis of lymphoid tissues and blood
Jacqueline H Y Siu, Michael J Pitcher, Thomas J Tull, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma
Zena N Willsmore, Lucy Booth, Akshay Patel, et al.
Cancers
|
October 16, 2024
Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma
Xinyi Chen, Shabana Habib, Madalina Alexandru, et al.
Page
of 3